You are here
The PETAL Network
The Clinical Trials Network for the Prevention and Early Treatment of Acute Lung Injury (PETAL Network) is a network of 12 Clinical Centers (CC) and 1 Clinical Coordinating Center (CCC) funded by the National Heart, Lung, and Blood Institute (NHLBI) to develop and conduct randomized controlled clinical trials to prevent or treat, and/or improve the outcome of patients who have, or who are at risk for, Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).
Major US Trial Closes Showing No Benefit for Hydroxychloroquine in COVID-19
June 20, 2020
On behalf of the PETAL Network, we are excited to share that two of the primary manuscripts have been published in the New England Journal of Medicine.